Michael Magrino, DO
General Surgery · Englewood, NJNPI 1619108867
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $389 of the $629 with a category attached, or 61.8%. 8 manufacturers reported payments, led by Davol Inc. at 54.7% of the total. Reporting peaked in 2019 at $333 and has fallen 71.0% since, to $96 in 2025.
Across 11 payments — averaging $57.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$344
- AbbVie$96
- W. L. Gore & Associates, Inc.$88
- Integra Lifesciences Corporation$31
- Reprise Biomedical, Inc.$27
- Takeda Pharmaceuticals U.S.A., Inc.$21
- plus $22 from 2 others
What the payments were for
- Travel & lodging$38962%
- Food & beverage$24038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 3 | $344 |
| AbbVie | 1 | $96 |
| W. L. Gore & Associates, Inc. | 1 | $88 |
| Integra Lifesciences Corporation | 1 | $31 |
| Reprise Biomedical, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $14 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PHASIX$301
How this compares
$629 in reported general payments places this provider in the 70th percentile of 39 general surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 57 | $150 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $150 |
| Hydromorphone Hcl | 19 | $78 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Englewood
- Nisha DhirPlainsboro$1.7M
- Adam KopelanMillburn$25K
- Steven DeakSomerset$19K
- Hee YangEnglewood Cliffs$17K
- Vadim GritsusPequannock$8K
- Stuart GeffnerLivingston$7K
- Michael MenackLakewood$5K
- Kenneth GoldmanPlainsboro$4K
- Lawrence JordanPlainsboro$4K
- Alexandra ErhardtHackensack$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.